30
/es/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
June 15, 2024
3512550
319423
2
Public Timelines FAQ
Public TimelinesFAQ
Public TimelinesFAQ
For educational institutions For teachers For students Open cabinet
For educational institutions For teachers For students Open cabinet
Crear
Create a timeline
Public timelines
Library
FAQ

1 ene 1997 año - Rituximab

Descripción:

For use in patients with treatment-resistant, low-grade or follicular B-cell non-Hodgkin lymphoma (NHL), the Food and Drug Administration (FDA) approves rituximab, a monoclonal antibody.

Añadido al timeline:

Cancer

ByTrinity Ozias
14 nov 2019
0
0
203

fecha:

1 ene 1997 año
Ahora mismo
~ 27 years ago
About & FeedbackAcuerdoPrivacidadBiblioteca
2024 © Time.Graphics
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews